---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-053765"
form_type: "8-K/A"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2025-04-14T23:59:59+00:00"
generated_at: "2026-05-23T15:22:27.918296+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Eledon Pharmaceuticals amends 8-K to correct auditor dismissal period; Crowe served only FY 2024

## Summary
- Corrects prior 8-K that inadvertently referenced Crowe LLP for fiscal year 2023.
- Audit Committee dismissed Crowe LLP and engaged Deloitte & Touche LLP on April 1, 2025.
- Crowe served as auditor from July 10, 2024 to April 1, 2025; no disagreements or reportable events.
- Deloitte engaged as independent auditor for fiscal year ending December 31, 2025.

## SEC filing metadata
- accession: 0000950170-25-053765
- form_type: 8-K/A
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2025-04-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000095017025053765/0000950170-25-053765-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000095017025053765/eldn-20250401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-053765
- JSON: https://secwatch.observer/filing/0000950170-25-053765.json
- Plain text: https://secwatch.observer/filing/0000950170-25-053765.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.